Modulation of Plasma 25-Hydroxyvitamin D3 Level by Imatinib Mesylate in Patients with Chronic Myelogenous Leukemia: The Role of Uptake and Efflux Transporters.
- DOI
- 10.1016/j.curtheres.2022.100684
- Published
- 2022
- Container
- Current therapeutic research, clinical and experimental
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1016/j.curtheres.2022.100684,
title = {Modulation of Plasma 25-Hydroxyvitamin D3 Level by Imatinib Mesylate in Patients with Chronic Myelogenous Leukemia: The Role of Uptake and Efflux Transporters.},
author = {Omran MM and Shouman SA and Abdelfattah R and Moussa HS and Thabet NA and Hamza MS},
year = {2022},
journal = {Current therapeutic research, clinical and experimental},
doi = {10.1016/j.curtheres.2022.100684},
url = {https://doi.org/10.1016/j.curtheres.2022.100684}
}RIS
TY - JOUR TI - Modulation of Plasma 25-Hydroxyvitamin D3 Level by Imatinib Mesylate in Patients with Chronic Myelogenous Leukemia: The Role of Uptake and Efflux Transporters. AU - Omran MM AU - Shouman SA AU - Abdelfattah R AU - Moussa HS AU - Thabet NA AU - Hamza MS PY - 2022 JO - Current therapeutic research, clinical and experimental DO - 10.1016/j.curtheres.2022.100684 UR - https://doi.org/10.1016/j.curtheres.2022.100684 ER -
APA
MM, O., SA, S., R, A., HS, M., NA, T., & MS, H. (2022). Modulation of Plasma 25-Hydroxyvitamin D3 Level by Imatinib Mesylate in Patients with Chronic Myelogenous Leukemia: The Role of Uptake and Efflux Transporters.. Current therapeutic research, clinical and experimental. https://doi.org/10.1016/j.curtheres.2022.100684
Source records
- pubmed · retrieved 2026-11-10T14:58:53.625Z